Clinical trials
Respiratory Tract Diseases trials in Denmark
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2011 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 5 |
| 2020 | 1 |
| 2023 | 1 |
| 2024 | 4 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Recruiting | 5 |
| Active, not recruiting | 4 |
| Enrolling by invitation | 1 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 5 |
| Eli Lilly and Company | 3 |
| Tor Biering-Sørensen | 3 |
| United Therapeutics | 2 |
| Emergency Medical Services, Capital Region, Denmark | 1 |
| GlaxoSmithKline | 1 |
| Grifols Therapeutics LLC | 1 |
| Pfizer | 1 |
| Rigshospitalet, Denmark | 1 |
| Ryme Medical, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Respiratory Tract Diseases | 24 |
| Lung Diseases | 15 |
| Lung Diseases, Obstructive | 5 |
| Bronchial Neoplasms | 4 |
| Carcinoma, Bronchogenic | 4 |
| Carcinoma, Non-Small-Cell Lung | 4 |
| Lung Neoplasms | 4 |
| Neoplasms | 4 |
| Neoplasms by Site | 4 |
| Pathologic Processes | 4 |
Trials
Showing 51 to 24 of 24. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.